M Cave
Concepts (254)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mycobacterium tuberculosis | 59 | 2013 | 266 | 3.980 |
Why?
| DNA Transposable Elements | 29 | 2006 | 103 | 1.770 |
Why?
| Tuberculosis | 26 | 2007 | 130 | 1.690 |
Why?
| DNA Fingerprinting | 23 | 2004 | 56 | 1.600 |
Why?
| DNA, Bacterial | 27 | 2007 | 186 | 1.040 |
Why?
| Tuberculosis, Pulmonary | 17 | 2013 | 105 | 0.950 |
Why?
| Polymorphism, Restriction Fragment Length | 22 | 2013 | 59 | 0.880 |
Why?
| Bacterial Typing Techniques | 7 | 2007 | 38 | 0.550 |
Why?
| Salmonella | 3 | 2004 | 26 | 0.540 |
Why?
| Antitubercular Agents | 11 | 2013 | 102 | 0.470 |
Why?
| Salmonella Infections | 3 | 2004 | 17 | 0.420 |
Why?
| Disease Outbreaks | 6 | 2007 | 120 | 0.370 |
Why?
| Macrophages | 4 | 2007 | 364 | 0.360 |
Why?
| Polymorphism, Genetic | 6 | 2007 | 180 | 0.350 |
Why?
| Polymerase Chain Reaction | 14 | 2006 | 449 | 0.340 |
Why?
| Salmonella typhimurium | 2 | 2006 | 48 | 0.320 |
Why?
| Tuberculosis, Multidrug-Resistant | 4 | 2004 | 40 | 0.310 |
Why?
| Repetitive Sequences, Nucleic Acid | 11 | 2006 | 95 | 0.300 |
Why?
| Th1 Cells | 1 | 2007 | 53 | 0.280 |
Why?
| Minisatellite Repeats | 1 | 2006 | 5 | 0.270 |
Why?
| Sputum | 10 | 2013 | 65 | 0.250 |
Why?
| Urban Health | 2 | 2013 | 28 | 0.250 |
Why?
| Genotype | 10 | 2013 | 533 | 0.240 |
Why?
| Chromosome Mapping | 3 | 2006 | 153 | 0.240 |
Why?
| Prisoners | 2 | 2004 | 93 | 0.240 |
Why?
| False Positive Reactions | 3 | 2001 | 59 | 0.230 |
Why?
| Electrophoresis, Gel, Pulsed-Field | 6 | 2006 | 29 | 0.230 |
Why?
| Humans | 59 | 2013 | 50503 | 0.220 |
Why?
| Base Sequence | 17 | 2000 | 639 | 0.210 |
Why?
| Campylobacter | 1 | 2002 | 5 | 0.200 |
Why?
| Campylobacter Infections | 1 | 2002 | 9 | 0.200 |
Why?
| Gryllidae | 3 | 1987 | 5 | 0.200 |
Why?
| Orthoptera | 3 | 1987 | 5 | 0.200 |
Why?
| Drug Resistance, Multiple | 2 | 2001 | 24 | 0.200 |
Why?
| RNA, Ribosomal | 4 | 1987 | 19 | 0.190 |
Why?
| Laboratories, Hospital | 1 | 2001 | 6 | 0.190 |
Why?
| Chickens | 1 | 2002 | 111 | 0.190 |
Why?
| Laboratories | 1 | 2001 | 19 | 0.190 |
Why?
| Equipment Contamination | 1 | 2001 | 19 | 0.190 |
Why?
| Rifampin | 4 | 2013 | 59 | 0.190 |
Why?
| Sequence Analysis, DNA | 6 | 2007 | 226 | 0.180 |
Why?
| DNA Probes | 4 | 1997 | 29 | 0.180 |
Why?
| AIDS-Related Opportunistic Infections | 5 | 2000 | 38 | 0.180 |
Why?
| Mycobacterium bovis | 4 | 2000 | 11 | 0.180 |
Why?
| Molecular Epidemiology | 5 | 2004 | 36 | 0.170 |
Why?
| Arkansas | 8 | 2006 | 1985 | 0.160 |
Why?
| Adult | 23 | 2013 | 13577 | 0.160 |
Why?
| Environmental Microbiology | 1 | 1999 | 7 | 0.160 |
Why?
| Molecular Sequence Data | 14 | 2005 | 778 | 0.160 |
Why?
| Male | 29 | 2013 | 25907 | 0.160 |
Why?
| Salmonella Food Poisoning | 1 | 1998 | 6 | 0.150 |
Why?
| Plasmids | 3 | 1996 | 164 | 0.150 |
Why?
| Risk Factors | 8 | 2013 | 3724 | 0.150 |
Why?
| Genes | 5 | 1987 | 32 | 0.140 |
Why?
| Middle Aged | 19 | 2006 | 12611 | 0.130 |
Why?
| Female | 26 | 2013 | 27081 | 0.130 |
Why?
| DNA, Ribosomal | 2 | 1986 | 28 | 0.130 |
Why?
| Genome, Bacterial | 4 | 2006 | 124 | 0.130 |
Why?
| RNA, Messenger | 4 | 1999 | 1089 | 0.120 |
Why?
| Gene Deletion | 2 | 2006 | 261 | 0.120 |
Why?
| Adolescent | 10 | 2006 | 6443 | 0.120 |
Why?
| Diet | 1 | 1998 | 568 | 0.110 |
Why?
| Bacterial Proteins | 7 | 2006 | 367 | 0.110 |
Why?
| Aged | 12 | 2006 | 9741 | 0.110 |
Why?
| Endemic Diseases | 1 | 2013 | 22 | 0.100 |
Why?
| Bacteriological Techniques | 6 | 1998 | 41 | 0.100 |
Why?
| Serotyping | 2 | 2004 | 11 | 0.100 |
Why?
| Cluster Analysis | 5 | 2002 | 219 | 0.100 |
Why?
| Evaluation Studies as Topic | 6 | 1996 | 107 | 0.100 |
Why?
| Mycobacterium | 7 | 1998 | 28 | 0.100 |
Why?
| Los Angeles | 4 | 1999 | 30 | 0.090 |
Why?
| RNA, Bacterial | 4 | 1999 | 58 | 0.090 |
Why?
| Gene Amplification | 4 | 1998 | 56 | 0.090 |
Why?
| Food Microbiology | 2 | 2002 | 48 | 0.090 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2000 | 572 | 0.080 |
Why?
| Tumor Necrosis Factor-alpha | 3 | 2007 | 393 | 0.080 |
Why?
| Blotting, Southern | 4 | 2000 | 41 | 0.080 |
Why?
| Colorado | 2 | 2001 | 21 | 0.080 |
Why?
| Type C Phospholipases | 2 | 2006 | 13 | 0.080 |
Why?
| Acyltransferases | 2 | 1999 | 25 | 0.080 |
Why?
| Retrospective Studies | 6 | 2013 | 6263 | 0.080 |
Why?
| Child, Preschool | 7 | 2006 | 3942 | 0.080 |
Why?
| Housing | 2 | 1999 | 46 | 0.080 |
Why?
| Child | 7 | 2006 | 6906 | 0.070 |
Why?
| Nucleic Acid Amplification Techniques | 2 | 1999 | 14 | 0.070 |
Why?
| Microbial Sensitivity Tests | 4 | 2004 | 269 | 0.070 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 234 | 0.070 |
Why?
| Infant | 5 | 2006 | 3628 | 0.070 |
Why?
| Species Specificity | 6 | 2001 | 187 | 0.070 |
Why?
| Drug Resistance, Multiple, Bacterial | 2 | 2004 | 64 | 0.070 |
Why?
| Cloning, Molecular | 5 | 1996 | 190 | 0.070 |
Why?
| Oligonucleotides | 3 | 2004 | 80 | 0.070 |
Why?
| Incidence | 3 | 2013 | 1032 | 0.060 |
Why?
| Prospective Studies | 4 | 2000 | 2378 | 0.060 |
Why?
| Mexico | 2 | 2004 | 35 | 0.060 |
Why?
| DNA Replication | 2 | 1976 | 156 | 0.060 |
Why?
| Sensitivity and Specificity | 5 | 1998 | 859 | 0.060 |
Why?
| United States | 4 | 2001 | 4955 | 0.060 |
Why?
| Seroepidemiologic Studies | 1 | 2004 | 50 | 0.060 |
Why?
| Water Microbiology | 1 | 2004 | 30 | 0.060 |
Why?
| Longitudinal Studies | 2 | 2004 | 735 | 0.060 |
Why?
| Antibiotics, Antitubercular | 2 | 2000 | 15 | 0.060 |
Why?
| Base Composition | 2 | 2000 | 29 | 0.050 |
Why?
| Population Surveillance | 1 | 2004 | 164 | 0.050 |
Why?
| Drug Resistance, Microbial | 4 | 1999 | 45 | 0.050 |
Why?
| Aged, 80 and over | 4 | 2003 | 3226 | 0.050 |
Why?
| Genetic Variation | 2 | 2002 | 207 | 0.050 |
Why?
| Urban Population | 2 | 2001 | 151 | 0.050 |
Why?
| Food Contamination | 1 | 2002 | 37 | 0.050 |
Why?
| Antigens, Bacterial | 2 | 1999 | 51 | 0.050 |
Why?
| Animals | 9 | 2002 | 13124 | 0.050 |
Why?
| Hospitals, Public | 1 | 2001 | 7 | 0.050 |
Why?
| Cytokines | 1 | 2004 | 606 | 0.050 |
Why?
| Occupational Diseases | 1 | 2002 | 82 | 0.050 |
Why?
| Nursing Homes | 1 | 2002 | 111 | 0.050 |
Why?
| Hospitals, University | 1 | 2001 | 77 | 0.050 |
Why?
| Confidence Intervals | 1 | 2001 | 154 | 0.050 |
Why?
| Probability | 1 | 2001 | 164 | 0.040 |
Why?
| Time Factors | 5 | 2013 | 2935 | 0.040 |
Why?
| Logistic Models | 2 | 2006 | 900 | 0.040 |
Why?
| Reproducibility of Results | 2 | 2001 | 1197 | 0.040 |
Why?
| Spain | 2 | 1997 | 16 | 0.040 |
Why?
| Rural Population | 2 | 2002 | 554 | 0.040 |
Why?
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2000 | 20 | 0.040 |
Why?
| Odds Ratio | 1 | 2001 | 551 | 0.040 |
Why?
| Cross Infection | 1 | 2000 | 94 | 0.040 |
Why?
| Histocytological Preparation Techniques | 1 | 1998 | 2 | 0.040 |
Why?
| DNA Restriction Enzymes | 3 | 1992 | 19 | 0.040 |
Why?
| Uganda | 2 | 2013 | 35 | 0.040 |
Why?
| Databases, Factual | 1 | 2001 | 673 | 0.040 |
Why?
| Gene Expression | 1 | 2000 | 610 | 0.040 |
Why?
| DNA Primers | 4 | 1999 | 206 | 0.040 |
Why?
| Radiography, Thoracic | 1 | 1997 | 64 | 0.040 |
Why?
| Analysis of Variance | 1 | 1998 | 552 | 0.030 |
Why?
| Molecular Probe Techniques | 1 | 1996 | 8 | 0.030 |
Why?
| Mycobacterium avium | 3 | 1998 | 8 | 0.030 |
Why?
| Bombyx | 1 | 1976 | 2 | 0.030 |
Why?
| Sigma Factor | 1 | 1996 | 22 | 0.030 |
Why?
| Diagnostic Errors | 1 | 1997 | 66 | 0.030 |
Why?
| Multigene Family | 1 | 1996 | 54 | 0.030 |
Why?
| Hemiptera | 1 | 1975 | 3 | 0.030 |
Why?
| Repressor Proteins | 1 | 1996 | 148 | 0.030 |
Why?
| Recurrence | 2 | 2013 | 659 | 0.030 |
Why?
| Case-Control Studies | 1 | 1998 | 1156 | 0.030 |
Why?
| Restriction Mapping | 2 | 1993 | 33 | 0.030 |
Why?
| Isoniazid | 3 | 2001 | 33 | 0.030 |
Why?
| Nucleic Acid Hybridization | 2 | 1991 | 55 | 0.030 |
Why?
| Drug Therapy, Combination | 3 | 2000 | 384 | 0.030 |
Why?
| Urine | 1 | 1994 | 24 | 0.030 |
Why?
| DNA-Binding Proteins | 1 | 1996 | 418 | 0.030 |
Why?
| Amplified Fragment Length Polymorphism Analysis | 1 | 2013 | 3 | 0.030 |
Why?
| Sequence Homology, Nucleic Acid | 2 | 1998 | 46 | 0.030 |
Why?
| HIV Infections | 2 | 2013 | 352 | 0.030 |
Why?
| Virulence | 2 | 2006 | 168 | 0.030 |
Why?
| Transcription Factors | 1 | 1996 | 565 | 0.030 |
Why?
| Coinfection | 1 | 2013 | 41 | 0.030 |
Why?
| Lung | 1 | 1996 | 504 | 0.020 |
Why?
| Proportional Hazards Models | 1 | 2013 | 415 | 0.020 |
Why?
| Kaplan-Meier Estimate | 1 | 2013 | 464 | 0.020 |
Why?
| Washington | 2 | 2006 | 47 | 0.020 |
Why?
| Multivariate Analysis | 1 | 2013 | 583 | 0.020 |
Why?
| Autoradiography | 1 | 1991 | 33 | 0.020 |
Why?
| Phenotype | 1 | 2013 | 739 | 0.020 |
Why?
| Epidemiologic Methods | 3 | 1997 | 46 | 0.020 |
Why?
| Infant, Newborn | 2 | 2006 | 2749 | 0.020 |
Why?
| Colony Count, Microbial | 2 | 1999 | 66 | 0.020 |
Why?
| Risk Assessment | 1 | 2013 | 1270 | 0.020 |
Why?
| Molecular Weight | 2 | 1985 | 82 | 0.020 |
Why?
| RNA, Ribosomal, 16S | 2 | 1999 | 112 | 0.020 |
Why?
| Paraffin Embedding | 2 | 1998 | 51 | 0.020 |
Why?
| Treatment Outcome | 2 | 2013 | 5283 | 0.020 |
Why?
| China | 1 | 2006 | 90 | 0.020 |
Why?
| Mutagenesis, Insertional | 1 | 2005 | 22 | 0.020 |
Why?
| Testis | 2 | 1976 | 66 | 0.020 |
Why?
| Ovary | 2 | 1976 | 103 | 0.020 |
Why?
| Transcription, Genetic | 1 | 1986 | 361 | 0.020 |
Why?
| Cell Nucleus | 2 | 1976 | 182 | 0.020 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 405 | 0.020 |
Why?
| Interleukin-10 | 1 | 2004 | 84 | 0.010 |
Why?
| Leukemia, Monocytic, Acute | 1 | 2004 | 5 | 0.010 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 2004 | 47 | 0.010 |
Why?
| Escherichia coli | 1 | 1985 | 190 | 0.010 |
Why?
| Interferon-gamma | 1 | 2004 | 177 | 0.010 |
Why?
| Tuberculin Test | 1 | 2002 | 8 | 0.010 |
Why?
| Hospitals, Community | 1 | 2002 | 19 | 0.010 |
Why?
| Rural Health | 1 | 2002 | 89 | 0.010 |
Why?
| Cell Line | 1 | 2004 | 988 | 0.010 |
Why?
| Risk | 1 | 2002 | 324 | 0.010 |
Why?
| Chi-Square Distribution | 1 | 2002 | 277 | 0.010 |
Why?
| Nontuberculous Mycobacteria | 1 | 1981 | 11 | 0.010 |
Why?
| DNA, Viral | 2 | 1997 | 136 | 0.010 |
Why?
| Cell Line, Tumor | 1 | 2004 | 1398 | 0.010 |
Why?
| Texas | 1 | 1999 | 142 | 0.010 |
Why?
| Nitrites | 1 | 1999 | 32 | 0.010 |
Why?
| Interleukins | 1 | 1999 | 31 | 0.010 |
Why?
| Immunocompromised Host | 1 | 2000 | 119 | 0.010 |
Why?
| Half-Life | 1 | 1999 | 86 | 0.010 |
Why?
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2000 | 81 | 0.010 |
Why?
| Fixatives | 1 | 1998 | 12 | 0.010 |
Why?
| Culture Media | 1 | 1999 | 93 | 0.010 |
Why?
| Chromosomes, Bacterial | 1 | 1998 | 14 | 0.010 |
Why?
| Mycobacterium Infections | 1 | 1998 | 10 | 0.010 |
Why?
| Diagnosis, Differential | 1 | 2002 | 1033 | 0.010 |
Why?
| Formaldehyde | 1 | 1998 | 49 | 0.010 |
Why?
| Monocytes | 1 | 1999 | 127 | 0.010 |
Why?
| Coloring Agents | 1 | 1998 | 66 | 0.010 |
Why?
| Binding, Competitive | 1 | 1998 | 94 | 0.010 |
Why?
| San Francisco | 1 | 1998 | 12 | 0.010 |
Why?
| Emigration and Immigration | 1 | 1998 | 17 | 0.010 |
Why?
| Granuloma | 1 | 1998 | 45 | 0.010 |
Why?
| Disease Transmission, Infectious | 1 | 1998 | 13 | 0.010 |
Why?
| Leukemia, Myeloid, Acute | 1 | 2000 | 181 | 0.010 |
Why?
| Mutation | 1 | 2004 | 1280 | 0.010 |
Why?
| Acquired Immunodeficiency Syndrome | 1 | 1998 | 53 | 0.010 |
Why?
| Substance Abuse, Intravenous | 1 | 1998 | 43 | 0.010 |
Why?
| HIV | 1 | 1997 | 25 | 0.010 |
Why?
| Demography | 1 | 1997 | 94 | 0.010 |
Why?
| Health Personnel | 1 | 2000 | 247 | 0.010 |
Why?
| Alkalies | 1 | 1996 | 4 | 0.010 |
Why?
| Mycobacterium leprae | 1 | 1996 | 8 | 0.010 |
Why?
| Sequence Homology | 1 | 1996 | 17 | 0.010 |
Why?
| Genes, Bacterial | 1 | 1996 | 58 | 0.010 |
Why?
| Exocrine Glands | 1 | 1976 | 1 | 0.010 |
Why?
| Cell Nucleolus | 1 | 1976 | 4 | 0.010 |
Why?
| Guanosine | 1 | 1996 | 5 | 0.010 |
Why?
| Polyploidy | 1 | 1976 | 11 | 0.010 |
Why?
| Medical Records | 1 | 1997 | 85 | 0.010 |
Why?
| Nucleic Acids | 1 | 1976 | 13 | 0.010 |
Why?
| Cattle | 1 | 1996 | 205 | 0.010 |
Why?
| Alcohol Drinking | 1 | 1998 | 227 | 0.010 |
Why?
| Tissue Fixation | 1 | 1996 | 34 | 0.010 |
Why?
| Adenosine | 1 | 1996 | 71 | 0.010 |
Why?
| DNA, Satellite | 1 | 1975 | 14 | 0.010 |
Why?
| Predictive Value of Tests | 1 | 1998 | 930 | 0.010 |
Why?
| Phylogeny | 1 | 1996 | 236 | 0.010 |
Why?
| Alleles | 1 | 1996 | 256 | 0.010 |
Why?
| Guanine | 1 | 1975 | 40 | 0.010 |
Why?
| Cytosine | 1 | 1975 | 30 | 0.010 |
Why?
| Cells, Cultured | 1 | 1999 | 1571 | 0.010 |
Why?
| Mummies | 1 | 1995 | 2 | 0.010 |
Why?
| History, Medieval | 1 | 1995 | 5 | 0.010 |
Why?
| Peru | 1 | 1995 | 8 | 0.010 |
Why?
| History, Ancient | 1 | 1995 | 8 | 0.010 |
Why?
| Amino Acid Sequence | 1 | 1996 | 574 | 0.010 |
Why?
| Oocytes | 1 | 1975 | 75 | 0.010 |
Why?
| Fatal Outcome | 1 | 1995 | 197 | 0.010 |
Why?
| Follow-Up Studies | 1 | 2000 | 2242 | 0.010 |
Why?
| DNA | 1 | 1975 | 535 | 0.010 |
Why?
| Antineoplastic Agents | 1 | 2000 | 1172 | 0.010 |
Why?
| Genetic Markers | 1 | 1991 | 104 | 0.010 |
Why?
| Electrophoresis, Agar Gel | 1 | 1990 | 11 | 0.010 |
Why?
| Temperature | 1 | 1990 | 162 | 0.010 |
Why?
| Mice | 1 | 1996 | 5687 | 0.000 |
Why?
| Bacteriophage Typing | 1 | 1981 | 1 | 0.000 |
Why?
|
|
Cave's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|